JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activities
January 15, 2019
Posted by: eric
Categories: Optio company news, Uncategorized
The Huntington’s market heats up – observations as Optio attends the November 2018 HSG congress.
November 11, 2018
Posted by: eric
Category: Uncategorized
Optio attends Huntington’s Disease Society of America 33rd annual convention – Los Angeles, June 2018
June 6, 2018
Posted by: eric
Category: Uncategorized
Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018
January 15, 2018
Posted by: admin
Categories: Optio company news, Uncategorized